Free Trial

Helius Medical Technologies Q4 2023 Earnings Report

Helius Medical Technologies logo
$0.91 +0.43 (+89.58%)
(As of 12/20/2024 05:45 PM ET)

Helius Medical Technologies EPS Results

Actual EPS
-$1.47
Consensus EPS
-$4.05
Beat/Miss
Beat by +$2.58
One Year Ago EPS
N/A

Helius Medical Technologies Revenue Results

Actual Revenue
$0.13 million
Expected Revenue
$0.18 million
Beat/Miss
Missed by -$50.00 thousand
YoY Revenue Growth
N/A

Helius Medical Technologies Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin

Helius Medical Technologies Earnings Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
Helius Medical Technologies (HSDT) Gets a Hold from Maxim Group
See More Helius Medical Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Helius Medical Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Helius Medical Technologies and other key companies, straight to your email.

About Helius Medical Technologies

Helius Medical Technologies (NASDAQ:HSDT), a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

View Helius Medical Technologies Profile

More Earnings Resources from MarketBeat

Upcoming Earnings